Literature DB >> 11239449

The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts.

A Cherukuri1, P C Cheng, H W Sohn, S K Pierce.   

Abstract

The CD19/CD21 complex functions to significantly enhance B cell antigen receptor (BCR) signaling in response to complement-tagged antigens. Recent studies showed that following antigen binding the BCR translocates into plasma membrane lipid rafts that serve as platforms for BCR signaling. Here, we show that the binding of complement-tagged antigens stimulates the translocation of both the BCR and the CD19/CD21 complex into lipid rafts, resulting in prolonged residency in and signaling from the rafts, as compared to BCR cross-linking alone. When coligated to the BCR, the CD19/CD21 complex retards the internalization and degradation of the BCR. The colocalization and stabilization of the BCR and the CD19/CD21 complex in plasma membrane lipid rafts represents a novel mechanism by which a coreceptor enhances BCR signaling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239449     DOI: 10.1016/s1074-7613(01)00098-x

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  39 in total

Review 1.  Role of CD19 signal transduction in B cell biology.

Authors:  Robert H Carter; Yue Wang; Stephen Brooks
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Specific recognition of macroscopic objects by the cell surface: evidence for a receptor density threshold revealed by micrometric particle binding characteristics.

Authors:  Stéphanie Sarda; David Pointu; Frédéric Pincet; Nelly Henry
Journal:  Biophys J       Date:  2004-05       Impact factor: 4.033

3.  Serum levels of soluble CD21 in patients with systemic sclerosis.

Authors:  Manabu Tomita; Takafumi Kadono; Norihito Yazawa; Tomohiko Kawashima; Zenshiro Tamaki; Ryuichi Ashida; Hanako Ohmatsu; Yoshihide Asano; Makoto Sugaya; Masahide Kubo; Hironobu Ihn; Kunihiko Tamaki; Shinichi Sato
Journal:  Rheumatol Int       Date:  2010-10-30       Impact factor: 2.631

4.  CD23+ CD21(high) CD1d(high) B cells in inflamed lymph nodes are a locally differentiated population with increased antigen capture and activation potential.

Authors:  Safiehkhatoon Moshkani; Igor I Kuzin; Funmilola Adewale; Johan Jansson; Iñaki Sanz; Edward M Schwarz; Andrea Bottaro
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

5.  Fluorescence resonance energy transfer in living cells reveals dynamic membrane changes in the initiation of B cell signaling.

Authors:  Hae Won Sohn; Pavel Tolar; Tian Jin; Susan K Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-11       Impact factor: 11.205

6.  Immunostimulant adjuvant patch enhances humoral and cellular immune responses to DNA immunization.

Authors:  Mikayel Mkrtichyan; Anahit Ghochikyan; Nina Movsesyan; Adrine Karapetyan; Gayane Begoyan; Jianmei Yu; Gregory M Glenn; Ted M Ross; Michael G Agadjanyan; David H Cribbs
Journal:  DNA Cell Biol       Date:  2008-01       Impact factor: 3.311

7.  Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright.

Authors:  Christian Schmidt; Dongkyoon Kim; Gregory C Ippolito; Hassan R Naqvi; Loren Probst; Shawn Mathur; German Rosas-Acosta; Van G Wilson; Athenia L Oldham; Martin Poenie; Carol F Webb; Philip W Tucker
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

Review 8.  Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.

Authors:  David H Cribbs
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-04       Impact factor: 4.388

9.  Multivalent Antigens for Promoting B and T Cell Activation.

Authors:  Nitasha R Bennett; Daniel B Zwick; Adam H Courtney; Laura L Kiessling
Journal:  ACS Chem Biol       Date:  2015-06-02       Impact factor: 5.100

10.  Ezrin tunes the magnitude of humoral immunity.

Authors:  Debasis Pore; Neetha Parameswaran; Ken Matsui; Matthew B Stone; Ichiko Saotome; Andrea I McClatchey; Sarah L Veatch; Neetu Gupta
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.